Today: 17 April 2026
MongoDB stock plunges after weak outlook and sales shake-up spook investors
3 March 2026
2 mins read

MongoDB stock plunges after weak outlook and sales shake-up spook investors

NEW YORK, March 2, 2026, 17:17 (EST)

  • MongoDB shares dropped over 20% after hours, following mixed guidance from the company.
  • MongoDB announced it’s losing both Chief Revenue Officer Paul Capombassis and President of Field Operations Cedric Pech, making way for a new chief customer officer.
  • Atlas cloud revenue climbed 29% for the quarter, with total customers now above 65,200.

Shares of MongoDB (MDB) plummeted over 20% in after-hours trading on Monday, following a fiscal 2027 forecast that missed Wall Street’s targets. The company also disclosed a shakeup in its sales leadership.

This drop carries weight—investors are treating guidance as the main yardstick this earnings cycle, not sparing even strong results if the outlook sours. With software names, any hint of caution in the forecast tends to yank growth expectations and valuations down fast.

MongoDB finds itself at the center of cloud budget debates, as enterprises weigh options for data storage, analytics, and the latest AI workloads. Atlas, the company’s managed cloud database, now leads growth and stands out as a top reason bulls stick with the stock.

MongoDB reported a 27% jump in fiscal fourth-quarter revenue, coming in at $695.1 million. Adjusted earnings landed at $1.65 per share, on a non-GAAP basis. For the first quarter, the company is guiding revenue between $659 million and $664 million, along with adjusted profit projected in the $1.15 to $1.19 per share range. MongoDB expects full-year revenue to fall between $2.86 billion and $2.90 billion. Non-GAAP metrics strip out certain expenses, including stock-based compensation.

MongoDB announced that both Chief Revenue Officer Paul Capombassis and President of Field Operations Cedric Pech are departing. Erica Volini steps in as chief customer officer starting March 3. Capombassis, for now, stays on as CRO through the end of the first quarter and will shift to an adviser role in the second quarter, as the company wraps up its search for his replacement, according to MongoDB.

MongoDB said Volini, with stints at Deloitte and ServiceNow, has a track record in driving partner-led growth. The company called the moves planned, adding its sales team has enough depth to manage smoothly.

MongoDB reported Atlas-related revenue of $502.6 million for the quarter, marking a 29% increase from the same period last year. As of Jan. 31, total customers topped 65,200, with Atlas customers making up roughly 63,900 of that total. The company said 2,799 customers generated at least $100,000 each in annualized recurring revenue. ARR, or annualized recurring revenue, reflects subscription run-rate based on contracted amounts and, for certain cloud services, on recent usage.

The company reported free cash flow of $176.7 million for the quarter, bringing the annual total to $492.6 million. By the end of January, it held around $2.4 billion in cash, cash equivalents, restricted cash, and short-term investments.

MongoDB turned in a “strong fourth quarter,” CEO CJ Desai said, citing better-than-expected operating margins. Desai called out the company’s “rule of 40” metrics, a standard gauge for software firms that blends growth and profitability. The company also showcased fresh AI features—embedding and reranking models, plus vector search—tools designed to boost software’s ability to locate similar content for AI-driven use cases.

According to a filing, MongoDB received notice from Pech on Feb. 27 of his plan to step down, with his resignation set for April 15. Stepping into the role, the board tapped Kong Phan—who previously served as Confluent’s chief accounting officer—to become MongoDB’s chief accounting officer and principal accounting officer, effective April 14. The filing also notes that MongoDB adopted new bylaws letting certain long-term shareholders nominate directors for inclusion on the company’s proxy card, a move referred to as proxy access.

First-quarter revenue estimates hovered near $662 million, but MongoDB’s earnings guidance missed earlier forecasts, according to FactSet numbers referenced by Investors Business Daily. Shares slumped over 22%, dropping to roughly $251 in late trading, the outlet said.

MongoDB faces off against Amazon and Microsoft’s cloud database offerings, plus an array of both open-source and proprietary rivals. Subscriptions make up a big chunk of its business. Yet the landscape can shift quickly—if customers pull back on Atlas spending, that hits the top line. There’s also fresh turnover: Two senior sales leaders have left, leaving MongoDB in search of a new CRO while it walks investors through plans for fiscal 2027.

Stock Market Today

  • GIFT Nifty Signals Positive Start, Eyes Key Resistance Levels
    April 16, 2026, 11:21 PM EDT. Indian equities ended Thursday modestly lower amid volatility from Sensex expiry despite support from a stronger rupee and Brent crude. GIFT Nifty futures gained 47 points to 24,218, hinting at a positive open. Analysts highlight immediate support between 23,100-23,450 and note a decisive close above 24,400 could accelerate gains toward 24,700-24,800. Conversely, failure to break 24,300 resistance may lead to profit booking with a dip near 24,000. India VIX, a gauge of market fear, declined 3.1% to 18.08. Globally, U.S. futures were steady amid hopes of a ceasefire in the Middle East. Oil prices softened as easing geopolitical tensions trimmed Brent crude to around $98 per barrel. Foreign investors bought shares worth Rs 382 crore while domestic investors sold Rs 3,428 crore. The rupee strengthened amid optimism over peace prospects and lower oil prices.

Latest article

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

Hims & Hers Health Stock Jumps as FDA Reconsiders Peptide Restrictions

16 April 2026
Hims & Hers Health shares rose to $26.65 Thursday after the FDA said it would reconsider restrictions on several peptides, removing 12 from a high-risk list and scheduling a July review of seven more. The move follows Hims’ March decision to stop advertising compounded GLP-1 drugs and expand branded offerings through Novo Nordisk. The company acquired a California peptide facility last year to bolster supply.
NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

NuScale Power Stock Whipsaws After U.S. Opens Door to Nuclear Loans, Space Reactor Push

16 April 2026
NuScale Power shares jumped to $13.23 before falling back to $11.52 Thursday after the White House ordered NASA to start a space-reactor program and Energy Secretary Chris Wright said initial U.S. reactors would likely get federal loans. NuScale remains the only U.S. firm with an approved small modular reactor design but has yet to secure firm orders or financing.
SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

SoFi Technologies Stock Rises as FedNow Instant Transfers Set Up April 29 Earnings Test

16 April 2026
SoFi Technologies shares rose 1.5% Thursday after launching instant bank transfers via its Galileo platform, allowing money to move between SoFi and outside banks in seconds. The stock traded near $19.08 in New York. Investors await first-quarter results April 29, with SoFi guiding to $1.04 billion in adjusted net revenue and 12 cents per share in adjusted earnings.
D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

D-Wave Quantum Stock Jumps Again as Nvidia’s Ising Launch Reignites Quantum Rally

16 April 2026
D-Wave Quantum shares climbed about 5% Thursday, extending a 22.6% surge after Nvidia launched Ising, a new AI model family for quantum computing. D-Wave traded at $21.81, up from last year’s lows, and reported 2025 revenue of $24.6 million with first-quarter 2026 bookings topping $32.8 million. The company completed its $250 million Quantum Circuits acquisition in January. Market cap stood near $8.4 billion.
Exxon Mobil stock price edges higher after-hours as oil jumps on Iran conflict; BofA lifts XOM target
Previous Story

Exxon Mobil stock price edges higher after-hours as oil jumps on Iran conflict; BofA lifts XOM target

Oracle stock rises 2.6% after hours — what ORCL investors watch before earnings
Next Story

Oracle stock rises 2.6% after hours — what ORCL investors watch before earnings

Go toTop